Zhang J - Search Results

1

Hepatocellular carcinoma: Mechanisms of progression and immunotherapy.

Jiang Y, Han QJ, Zhang J. Jiang Y, et al. Among authors: zhang j. World J Gastroenterol. 2019 Jul 7;25(25):3151-3167. doi: 10.3748/wjg.v25.i25.3151. World J Gastroenterol. 2019. PMID: 31333308 Free PMC article. Review.

2

Targeting blockage of STAT3 inhibits hepatitis B virus-related hepatocellular carcinoma.

Yang Y, Zheng B, Han Q, Zhang C, Tian Z, Zhang J. Yang Y, et al. Among authors: zhang c, zhang j. Cancer Biol Ther. 2016 Apr 2;17(4):449-56. doi: 10.1080/15384047.2016.1156257. Cancer Biol Ther. 2016. PMID: 26934469 Free PMC article. Review.

3

HCC-Derived Exosomes: Critical Player and Target for Cancer Immune Escape.

Han Q, Zhao H, Jiang Y, Yin C, Zhang J. Han Q, et al. Among authors: zhang j. Cells. 2019 Jun 8;8(6):558. doi: 10.3390/cells8060558. Cells. 2019. PMID: 31181729 Free PMC article. Review.

4

Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.

Jiang Y, Han Q, Zhao H, Zhang J. Jiang Y, et al. Among authors: zhang j. J Exp Clin Cancer Res. 2021 Jan 6;40(1):13. doi: 10.1186/s13046-020-01808-3. J Exp Clin Cancer Res. 2021. PMID: 33407720 Free PMC article.

5

The Mechanisms of HBV-Induced Hepatocellular Carcinoma.

Jiang Y, Han Q, Zhao H, Zhang J. Jiang Y, et al. Among authors: zhang j. J Hepatocell Carcinoma. 2021 May 20;8:435-450. doi: 10.2147/JHC.S307962. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 34046368 Free PMC article. Review.

6

Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells.

Han QJ, Mu YL, Zhao HJ, Zhao RR, Guo QJ, Su YH, Zhang J. Han QJ, et al. Among authors: zhang j. World J Gastroenterol. 2021 Jun 28;27(24):3581-3594. doi: 10.3748/wjg.v27.i24.3581. World J Gastroenterol. 2021. PMID: 34239271 Free PMC article.

7

Innate and adaptive immune escape mechanisms of hepatitis B virus.

Zhao HJ, Hu YF, Han QJ, Zhang J. Zhao HJ, et al. Among authors: zhang j. World J Gastroenterol. 2022 Mar 7;28(9):881-896. doi: 10.3748/wjg.v28.i9.881. World J Gastroenterol. 2022. PMID: 35317051 Free PMC article. Review.

8

Immunotherapy for hepatoma using a dual-function vector with both immunostimulatory and pim-3-silencing effects.

Guo Q, Lan P, Yu X, Han Q, Zhang J, Tian Z, Zhang C. Guo Q, et al. Among authors: zhang c, zhang j. Mol Cancer Ther. 2014 Jun;13(6):1503-13. doi: 10.1158/1535-7163.MCT-13-0722. Epub 2014 Apr 10. Mol Cancer Ther. 2014. PMID: 24723452

9

NK cells are the crucial antitumor mediators when STAT3-mediated immunosuppression is blocked in hepatocellular carcinoma.

Sui Q, Zhang J, Sun X, Zhang C, Han Q, Tian Z. Sui Q, et al. Among authors: zhang c, zhang j. J Immunol. 2014 Aug 15;193(4):2016-23. doi: 10.4049/jimmunol.1302389. Epub 2014 Jul 11. J Immunol. 2014. PMID: 25015826

10

miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression.

Sun X, Zhang J, Hou Z, Han Q, Zhang C, Tian Z. Sun X, et al. Among authors: zhang c, zhang j. Cell Cycle. 2015;14(2):243-52. doi: 10.4161/15384101.2014.977112. Cell Cycle. 2015. PMID: 25607648 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180,165 results

Search Page

Filters